Filing Details

Accession Number:
0001209191-21-021966
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-18 21:42:28
Reporting Period:
2021-03-16
Accepted Time:
2021-03-18 21:42:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534248 Chemomab Therapeutics Ltd. CMMB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1211060 Peter Thiel 9200 Sunset Boulevard
Suite 1110
West Hollywood CA 90069
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Acquisiton 2021-03-16 230,536 $0.00 1,108,509 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
American Depositary Shares American Depositary Shares Purchase Warrant Acquisiton 2021-03-16 23,054 $0.00 23,054 $17.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,054 2021-03-17 2026-03-17 No 4 P Indirect
Footnotes
  1. The purchase reported herein was made in a private placement transaction entered into directly with the Issuer.
  2. Each American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares of the Issuer.
  3. Reported securities purchased in the private placement transaction as one ADS and one-tenth of one warrant (each whole warrant exercisable to purchase one ADS) for a combined price of $17.3509 per unit.
  4. These securities are held of record by Rivendell Investments 2017-9 LLC. The Reporting Person is the beneficial owner of Rivendell Investments 2017-9 LLC and has sole voting and investment power over the securities held by Rivendell Investments 2017-9 LLC.